Biffen M[au] - Search Results

Year	Number of Results
1987	1
1989	2
1990	2
1992	3
1993	2
1994	2
2002	1
2007	1
2012	2
2013	1
2016	1
2017	1
2018	1
2023	0

1

The role of CD45 in T-cell activation--resolving the paradoxes?

Alexander D, Shiroo M, Robinson A, Biffen M, Shivnan E. Alexander D, et al. Among authors: biffen m. Immunol Today. 1992 Dec;13(12):477-81. doi: 10.1016/0167-5699(92)90021-X. Immunol Today. 1992. PMID: 1463579 Review.

2

Phosphoinositides and plant growth substance action.

Hanke DE, Biffen M, Davies H. Hanke DE, et al. Among authors: biffen m. Symp Soc Exp Biol. 1990;44:193-205. Symp Soc Exp Biol. 1990. PMID: 1966635 Review.

3

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

Delaney S, Biffen M, Maltby J, Bell J, Asimus S, Aggarwal A, Kraan M, Keeling D. Delaney S, et al. Among authors: biffen m. BMJ Open Respir Res. 2016 Feb 23;3(1):e000113. doi: 10.1136/bmjresp-2015-000113. eCollection 2016. BMJ Open Respir Res. 2016. PMID: 26933507 Free PMC article.

4

Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease?

Naylor EJ, Bakstad D, Biffen M, Thong B, Calverley P, Scott S, Hart CA, Moots RJ, Edwards SW. Naylor EJ, et al. Among authors: biffen m. Am J Respir Cell Mol Biol. 2007 Aug;37(2):135-43. doi: 10.1165/rcmb.2006-0375OC. Epub 2007 Mar 15. Am J Respir Cell Mol Biol. 2007. PMID: 17363778

5

Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist.

Matsui H, Tomizawa H, Eiho K, Kashiwazaki Y, Edwards S, Biffen M, Bell JP, Bahl A, Leishman AJ, Murray CM, Takaku H, Ueda Y. Matsui H, et al. Among authors: biffen m. J Immunol. 2012 Dec 1;189(11):5194-205. doi: 10.4049/jimmunol.1101331. Epub 2012 Nov 2. J Immunol. 2012. PMID: 23125414

6

Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach.

Bell J, Dymond M, Biffen M, Delaney S, Keeling D, Zhang H, Robinson I. Bell J, et al. Among authors: biffen m. Toxicol Appl Pharmacol. 2018 Jan 1;338:9-19. doi: 10.1016/j.taap.2017.11.002. Epub 2017 Nov 6. Toxicol Appl Pharmacol. 2018. PMID: 29122671

7

Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity.

Biffen M, Matsui H, Edwards S, Leishman AJ, Eiho K, Holness E, Satterthwaite G, Doyle I, Wada H, Fraser NJ, Hawkins SL, Aoki M, Tomizawa H, Benjamin AD, Takaku H, McInally T, Murray CM. Biffen M, et al. Br J Pharmacol. 2012 May;166(2):573-86. doi: 10.1111/j.1476-5381.2011.01790.x. Br J Pharmacol. 2012. PMID: 22122192 Free PMC article.

8

Reduction in the level of intracellular myo-inositol in cultured soybean (Glycine max) cells inhibits cell division.

Biffen M, Hanke DE. Biffen M, et al. Biochem J. 1990 Feb 1;265(3):809-14. doi: 10.1042/bj2650809. Biochem J. 1990. PMID: 2306214 Free PMC article.

9

TLR7 stimulation of APCs results in inhibition of IL-5 through type I IFN and Notch signaling pathways in human peripheral blood mononuclear cells.

Edwards S, Jones C, Leishman AJ, Young BW, Matsui H, Tomizawa H, Murray CM, Biffen M. Edwards S, et al. Among authors: biffen m. J Immunol. 2013 Mar 15;190(6):2585-92. doi: 10.4049/jimmunol.1200780. Epub 2013 Feb 4. J Immunol. 2013. PMID: 23382558

10

The CD45 tyrosine phosphatase regulates specific pools of antigen receptor-associated p59fyn and CD4-associated p56lck tyrosine in human T-cells.

Biffen M, McMichael-Phillips D, Larson T, Venkitaraman A, Alexander D. Biffen M, et al. EMBO J. 1994 Apr 15;13(8):1920-9. doi: 10.1002/j.1460-2075.1994.tb06461.x. EMBO J. 1994. PMID: 8168490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results